Key Takeaways
- •Purotoxin-1 comes from the venom of Geolycosa spiders and targets P2X3 receptors with high selectivity.
- •Researchers identified Purotoxin-1 as the initial compound to act solely on the P2X3 receptor-channel complex.
- •Purotoxin-1 consists of 35 amino acid residues.
Discovery of a Selective P2X3 Inhibitor
Purotoxin-1 comes from the venom of Geolycosa spiders and targets P2X3 receptors with high selectivity. These receptors form part of the peripheral nociception system. Before this peptide, no modulators in the purinoreceptor family could affect just one subtype.
Researchers identified Purotoxin-1 as the initial compound to act solely on the P2X3 receptor-channel complex. This selectivity aids studies of receptor structure and function. For more on peptide structures, check the Peptide Glossary.
Peptide Structure and Composition
Purotoxin-1 consists of 35 amino acid residues. Eight of these are cysteines that form four disulfide bonds.
This structure supports its specific binding properties. Such features are common in venom-derived peptides used in research.
Mechanism of Action on P2X3 Receptors
Purotoxin-1 inhibits by extending the time needed for P2X3 desensitization to recover, in a way that depends on its concentration. With prolonged agonist exposure in the peptide's presence, this inhibition shifts to potentiation.
Desensitized receptors gain a high-affinity site for the agonist. Agonist unbinding matches the desensitization recovery rate. Preliminary findings show Purotoxin-1 binds allosterically, without competing at the agonist site.
Selectivity Testing Across Receptor Types
Tests examined Purotoxin-1's impact on P2X2, P2X3, and P2X2/3 receptor-channel complexes. Results confirmed high selectivity for P2X3 alone.
The peptide also alters ion currents in mammalian dorsal root ganglia (DRG) neurons driven by P2X3 activation. It causes a minor initial potentiation of P2X3 currents but strongly reduces later ATP responses on desensitized receptors. All effects reverse completely.
Antinociceptive Effects in Rat Pain Models
In rats with inflammation, intraplantar Purotoxin-1 injection into the hind paw reduced thermal hyperalgesia from carrageenan or complete Freund's adjuvant, as measured by the Hargreaves plantar test.
It also lowered nocifensive events from capsaicin or formalin injections. In the formalin test, reductions occurred mainly in phase two, not phase one.
High Affinity and Exclusive Selectivity
Purotoxin-1 binds P2X3 receptors with an EK50 of 12 nM. At 100 nM, it fully blocks currents from these complexes, a saturating dose.
No other voltage- or ligand-gated channels in rat DRG neuron membranes respond to 100 nM Purotoxin-1. This underscores its precise targeting of the P2X3 subtype. Tools like the Peptide Dosage & Cycle Planner can help with research dosing calculations.
Key Studies and References
- Grishin, E. V., Savchenko, G. A., Vassilevski, A. A., Korolkova, Y. V., Boychuk, Y. A., Viatchenko‐Karpinski, V. Y., ... & Voitenko, N. V. (2010). Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain. Annals of neurology, 67 (5), 680-683.
- Kabanova, N. V., Vassilevski, A. A., Rogachevskaja, O. A., Bystrova, M. F., Korolkova, Y. V., Pluzhnikov, K. A., ... & Kolesnikov, S. S. (2012). Modulation of P2X3 receptors by spider toxins. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1818 (11), 2868-2875.
- Savchenko, G. A., Volkova, T. M., Vasilevskii, A. A., Korol'kova, Y. V., Grishin, E. V., Boichouk, Y. A., & Krishtal, O. A. (2011). Purinergic Membrane Receptors as Targets for the Effect of Purotoxin 1, a Component of Venom of Spiders from the Geolycosa Genus. Neurophysiology, 42 (6), 387-391.
Purotoxin-1 stands out for its targeted action on P2X3 receptors in pain pathways. Its reversibility and lack of off-target effects make it valuable for nociception research. Explore more peptides in our catalog or use free peptide tools for experiments.
